Business Description
Kainos Medicine Inc
ISIN : KR7284620002
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 15.43 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.83 | |||||
Beneish M-Score | 5.47 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 1.7 | |||||
3-Year EPS without NRI Growth Rate | -0.4 | |||||
3-Year FCF Growth Rate | -18.4 | |||||
3-Year Book Growth Rate | -7.6 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.86 | |||||
9-Day RSI | 20.33 | |||||
14-Day RSI | 25.58 | |||||
6-1 Month Momentum % | 23.78 | |||||
12-1 Month Momentum % | 46.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.51 | |||||
Quick Ratio | 2.51 | |||||
Cash Ratio | 1.96 | |||||
Days Sales Outstanding | 112.79 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.4 | |||||
Shareholder Yield % | 4.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.73 | |||||
Operating Margin % | -1914.67 | |||||
Net Margin % | -1768.38 | |||||
FCF Margin % | -1721.04 | |||||
ROE % | -109.76 | |||||
ROA % | -56.61 | |||||
ROIC % | -146.99 | |||||
ROC (Joel Greenblatt) % | -1251.47 | |||||
ROCE % | -77.69 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 127.99 | |||||
PB Ratio | 13.23 | |||||
Price-to-Tangible-Book | 15.03 | |||||
EV-to-EBIT | -6.49 | |||||
EV-to-EBITDA | -7.27 | |||||
EV-to-Revenue | 115.46 | |||||
EV-to-FCF | -6.94 | |||||
Price-to-Net-Current-Asset-Value | 39.84 | |||||
Earnings Yield (Greenblatt) % | -15.4 | |||||
FCF Yield % | -13.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kainos Medicine Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 620.088 | ||
EPS (TTM) (â‚©) | -394 | ||
Beta | 1.59 | ||
Volatility % | 66.94 | ||
14-Day RSI | 25.58 | ||
14-Day ATR (â‚©) | 397.228714 | ||
20-Day SMA (â‚©) | 3989.5 | ||
12-1 Month Momentum % | 46.33 | ||
52-Week Range (â‚©) | 2275 - 7100 | ||
Shares Outstanding (Mil) | 27.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kainos Medicine Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kainos Medicine Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kainos Medicine Inc Frequently Asked Questions
What is Kainos Medicine Inc(XKRX:284620)'s stock price today?
When is next earnings date of Kainos Medicine Inc(XKRX:284620)?
Does Kainos Medicine Inc(XKRX:284620) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |